Celldex Therapeutics buy Barclays PLC
Start price
08.05.26
/
50%
€28.82
Target price
08.05.27
€40.93
Performance (%)
-13.78%
Price
03.06.26
€24.50
Summary
This prediction is currently active. The price of Celldex Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -13.78%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | -6.274% |
| iShares Core DAX® | -1,76 % |
| iShares Nasdaq 100 | 2,32 % |
| iShares Nikkei 225® | 5,02 % |
| iShares S&P 500 | 0,80 % |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Barclays PLC from $45.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.16
20.04.26
20.04.26
€38.28
20.04.27
20.04.27
-14.78%
03.06.26
03.06.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
12.43%
03.06.26
03.06.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
17.84%
03.06.26
03.06.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
7.11%
03.06.26
03.06.26